5LEBOVITZ H, DDE J F, PATWARDHAN R, et al. Rosiglitazone monotherapy is effective in patients with type 2diabetes[ J]. J Clin Endocfinol Metab, 2001, 86 : 280 - 288.
6MATTEWS D R, HOSKER J P, RUDENSKi A S, et al. Homeostasis model assessment : Insulin resistance and beta - cell function from fasting plasma glucose and insulin concentration in man [ J ]. Diabetologia, 1985, 28 : 412 -419.
7YAMAGISHI S, TAKEUCHI M. Telmisartan is a promising cardiometabolic sartan due to its unique PPAR -gamma- inducing property[J]. Med Hypotheses, 2005, 64 ( 3 ) :476 - 478.
8KURTZ T W, PRAVENEC M. Antidiabetic mechanisms of angiotensin - converting enzyme inhibitors and angiotensin Ⅱ receptor antagonists : beyond the renin - angiotensin system [ J ]. J Hypertens, 2004, 22(12) : 2 253 -2 261.
9DOGGRELL S A. Telmisartan - killing two birds with one stone [J]. Expert Opin Pharmacother, 2004, 5( 11 ): 2 397-2 400.
10DE GASPARO M, LEVENS N. Does blockade of angiotensin Ⅱreceptors offer clinical benefits over inhibition of angiotensin - converting enzyme? [J]. Pharmacol Toxicol, 1998, 82:257-271.
